找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Contemporary Bone Marrow Transplantation; Mammen Chandy,Vivek S. Radhakrishnan,Reghu K. Suku Reference work 2021 Springer Nature Switzerla

[复制链接]
查看: 7900|回复: 58
发表于 2025-3-21 18:09:16 | 显示全部楼层 |阅读模式
书目名称Contemporary Bone Marrow Transplantation
编辑Mammen Chandy,Vivek S. Radhakrishnan,Reghu K. Suku
视频video
概述Offers an authoritative source for transplant professionals.Updates on insights about technique and basic science.Addresses the supportive care of transplant patients and illustrates practical challen
丛书名称Organ and Tissue Transplantation
图书封面Titlebook: Contemporary Bone Marrow Transplantation;  Mammen Chandy,Vivek S. Radhakrishnan,Reghu K. Suku Reference work 2021 Springer Nature Switzerla
描述Bone Marrow transplantation or Hematopoietic stem cell transplantation is a life saving procedure in a number of diseases,hematological and non hematological, which fail alternative medical management or have no other treatment options. It has transformed the lives of thousands of patients and their families around the world battling with fatal or debilitating diseases.There are many unique aspects of bone marrow transplantation which makes it very different from solid organ transplants.  There is an enormous amount of research going on in this field both at clinical and basic science levels.With the rapidly changing world and field of transplantation, there is a need for an authoritative and up to date resource for transplant professionals..This book titled Contemporary Bone Marrow Transplantation aims to be a reference text comprehensively covering  various facets of hematopoietic stem cell transplants with latest insights about the technique and basic science.behind it . The book is the product of collective effort of transplant professionals round the world, and will reflect their experience as well as the current standard of care practices in Stem cell transplantation.The book
出版日期Reference work 2021
关键词Hematopoietic stem cells; stem cell transplant; Haploidentical stem cell transplantation; Immunosuppres
版次1
doihttps://doi.org/10.1007/978-3-030-36358-1
isbn_ebook978-3-030-36358-1Series ISSN 2570-1592 Series E-ISSN 2570-1606
issn_series 2570-1592
copyrightSpringer Nature Switzerland AG 2021
The information of publication is updating

书目名称Contemporary Bone Marrow Transplantation影响因子(影响力)




书目名称Contemporary Bone Marrow Transplantation影响因子(影响力)学科排名




书目名称Contemporary Bone Marrow Transplantation网络公开度




书目名称Contemporary Bone Marrow Transplantation网络公开度学科排名




书目名称Contemporary Bone Marrow Transplantation被引频次




书目名称Contemporary Bone Marrow Transplantation被引频次学科排名




书目名称Contemporary Bone Marrow Transplantation年度引用




书目名称Contemporary Bone Marrow Transplantation年度引用学科排名




书目名称Contemporary Bone Marrow Transplantation读者反馈




书目名称Contemporary Bone Marrow Transplantation读者反馈学科排名




单选投票, 共有 1 人参与投票
 

0票 0.00%

Perfect with Aesthetics

 

0票 0.00%

Better Implies Difficulty

 

1票 100.00%

Good and Satisfactory

 

0票 0.00%

Adverse Performance

 

0票 0.00%

Disdainful Garbage

您所在的用户组没有投票权限
发表于 2025-3-21 20:30:21 | 显示全部楼层
发表于 2025-3-22 01:11:42 | 显示全部楼层
发表于 2025-3-22 05:01:43 | 显示全部楼层
发表于 2025-3-22 10:30:24 | 显示全部楼层
Chimerism in Hematopoietic Stem Cell Transplantationes in the successful engraftment of the donor stem cells in the host environment. The degree of donor cell component in the recovering hematopoiesis in the host is a critical factor which affects posttransplant immunomodulation, relapse of primary disease, posttransplant complications, and ultimatel
发表于 2025-3-22 15:08:01 | 显示全部楼层
HSCT in Malignanciesers or solid organ cancer. The better understanding of disease physiopathology and the continuous development of new therapeutic strategies has an incessant impact in HCT indication. In addition, the refinement in HCT techniques and supportive care has remarkable reduced transplant-related mortality
发表于 2025-3-22 19:44:42 | 显示全部楼层
发表于 2025-3-23 00:12:24 | 显示全部楼层
Hemopoietic Stem Cell Transplant for Non-hematological Disordersrders is perhaps less obvious since the blood cells themselves function normally and there is no malignancy. The application of HCT in non-hematological disease is a growing area and is likely to concern all transplant physicians in the coming decades..HCT in leukemia is intuitive, even to the lay p
发表于 2025-3-23 02:50:36 | 显示全部楼层
Allogeneic Transplant Overview and Matched Related Donor Transplantignancies and other malignant and nonmalignant diseases. Since the first allogeneic transplants more than five decades ago, significant advances have occurred in transplantation technology, donor availability, and supportive care that have made transplantation safer and increasingly available to pat
发表于 2025-3-23 05:38:57 | 显示全部楼层
Haploidentical Transplantation: Challenges and Solutions hematological malignancies. The primary reason for this has been the emergence of posttransplantation cyclophosphamide as graft-versus-host disease (GVHD) prophylaxis, which by dint of both, its ease of application and impressive outcomes, has made HFD-HCT feasible across the globe. Studies have co
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-6-26 03:09
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表